Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Site-specific characteristics of infants developing bronchopulmonary dysplasia

Journal of Perinatology volume 26, pages 428–435 (2006)Cite this article

An Erratum to this article was published on 27 July 2006

Abstract

Hypothesis:

Site-specific variables that contribute to the pathogenesis of bronchopulmonary dysplasia (BPD) can be identified.

Objectives:

To evaluate the demographic, nutrition and growth characteristics of infants at risk for developing BPD at two neonatal intensive care units (NICUs: sites A and O).

Study Design:

Records of 306 infants of <30 weeks gestational age (GA) who survived to at least 36 weeks postmenstrual age were retrospectively reviewed. Data were obtained for maternal and neonatal demographics, weights, total fluids, calories, carbohydrate, protein and fat intake at birth, 7, 14, 21 and 28 days of life.

Results:

BPD rates were not different at the two sites. No statistical differences were noted in the incidence of maternal chorioamnionitis, pregnancy-induced hypertension or use of antenatal steroids among infants who developed BPD (n=169) and those who did not (n=137). White race, birth weight, respiratory distress syndrome requiring surfactant, sepsis and patent ductus arteriosus were significantly associated (all P⩽0.03) with BPD. After controlling for significant confounding variables, infants who developed BPD had significantly (P<0.001) less weight gain, received less calories and fat in the first postnatal month. In the 26 to 28 weeks GA group, the odds of getting BPD were 5.4 (95%CI: 1.4 to 21.3) times greater for site A than site O (P=0.017).

Conclusion:

Our analysis suggests that while some decrease in BPD can be achieved by focusing on ventilation/oxygen use, this approach is unlikely to impact on the youngest infants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Abbreviations

BW:

birth weight

BPD:

bronchopulmonary dysplasia

GA:

gestational age

IVH:

intraventricular hemorrhage

NEC:

necrotizing enterocolitis

PMA:

postmenstrual age

PDA:

patent ductus arteriosus

PIH:

pregnancy-induced hypertension

PNS:

postnatal steroids

PVL:

periventricular leukomalacia

RDS:

respiratory distress syndrome

TPN:

total parenteral nutrition

References

  1. Fanaroff AA, Hack M, Walsh MC . The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003; 27: 281–287.

    Article  PubMed  Google Scholar 

  2. Bhandari A, Bhandari V . Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 2003; 8: e370–380.

    Article  CAS  PubMed  Google Scholar 

  3. Egreteau L, Pauchard JY, Semama DS, Matis J, Liska A, Romeo B et al. Chronic oxygen dependency in infants born at less than 32 weeks' gestation: incidence and risk factors. Pediatrics 2001; 108: E26.

    Article  CAS  PubMed  Google Scholar 

  4. Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.

    Article  CAS  PubMed  Google Scholar 

  5. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305–1311.

    Article  PubMed  Google Scholar 

  6. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527–532.

    CAS  PubMed  Google Scholar 

  7. Ballard JL, Novak KK, Driver M . A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979; 95: 769–774.

    Article  CAS  PubMed  Google Scholar 

  8. Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500?gm. J Pediatr 1978; 92: 529–534.

    Article  CAS  PubMed  Google Scholar 

  9. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 26–30.

    CAS  PubMed  Google Scholar 

  11. Todd DA, Jana A, John E . Chronic oxygen dependency in infants born at 24–32 weeks' gestation: the role of antenatal and neonatal factors. J Paediatr Child Health 1997; 33: 402–407.

    Article  CAS  PubMed  Google Scholar 

  12. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171–176.

    Article  PubMed  Google Scholar 

  13. Redline RW, Wilson-Costello D, Hack M . Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002; 52: 713–719.

    Article  PubMed  Google Scholar 

  14. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004; 55: 1009–1017.

    Article  CAS  PubMed  Google Scholar 

  15. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000; 105: 1194–1201.

    Article  CAS  PubMed  Google Scholar 

  16. Stevens TP, Blennow M, Soll RF . Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2004; 3: CD003063.

    Google Scholar 

  17. Khalaf MN, Brodsky N, Hurley J, Bhandari V . A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics 2001; 108: 13–17.

    Article  CAS  PubMed  Google Scholar 

  18. Santin R, Brodsky N, Bhandari V . A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants &gt; or =28 weeks with respiratory distress syndrome (RDS). J Perinatol 2004; 24: 487–493.

    Article  PubMed  Google Scholar 

  19. Palta M, Gabbert D, Weinstein MR, Peters ME . Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. The newborn lung project. J Pediatr 1991; 119: 285–292.

    Article  CAS  PubMed  Google Scholar 

  20. Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KC . Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 1992; 120: 938–946.

    Article  CAS  PubMed  Google Scholar 

  21. Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005; 147: 786–790.

    Article  PubMed  Google Scholar 

  22. Bhandari V, Brodsky N, Porat R . Improved outcome of extremely low birth weight infants with Tegaderm application to skin. J Perinatol 2005; 25: 276–281.

    Article  PubMed  Google Scholar 

  23. Davidson S, Schrayer A, Wielunsky E, Krikler R, Lilos P, Reisner SH . Energy intake, growth, and development in ventilated very-low-birth-weight infants with and without bronchopulmonary dysplasia. Am J Dis Child 1990; 144: 553–559.

    CAS  PubMed  Google Scholar 

  24. Yu VY, Orgill AA, Lim SB, Bajuk B, Astbury J . Growth and development of very low birthweight infants recovering from bronchopulmonary dysplasia. Arch Dis Child 1983; 58: 791–794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Weinstein MR, Oh W . Oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr 1981; 99: 958–961.

    Article  CAS  PubMed  Google Scholar 

  26. Brunton JA, Saigal S, Atkinson SA . Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr 1998; 133: 340–345.

    Article  CAS  PubMed  Google Scholar 

  27. Kurzner SI, Garg M, Bautista DB, Bader D, Merritt RJ, Warburton D et al. Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics 1988; 81: 379–384.

    CAS  PubMed  Google Scholar 

  28. Frank L, Sosenko IR . Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis 1988; 138: 725–729.

    Article  CAS  PubMed  Google Scholar 

  29. Bhandari V, Fall P, Raisz L, Rowe J . Potential biochemical growth markers in premature infants. Am J Perinatol 1999; 16: 339–349.

    Article  CAS  PubMed  Google Scholar 

  30. Bhandari V, Burke G, Price M, Hussain N . Growth failure in infants developing severe BPD occurs by week 3 of postnatal life. Pediatr Res 1997; 41: 140A.

    Article  Google Scholar 

  31. Wilson DC, McClure G, Halliday HL, Reid MM, Dodge JA . Nutrition and bronchopulmonary dysplasia. Arch Dis Child 1991; 66: 37–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. deRegnier RA, Guilbert TW, Mills MM, Georgieff MK . Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia. J Nutr 1996; 126: 168–175.

    Article  CAS  PubMed  Google Scholar 

  33. Frank L . Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 541–562.

    Article  CAS  PubMed  Google Scholar 

  34. Helbock HJ, Motchnik PA, Ames BN . Toxic hydroperoxides in intravenous lipid emulsions used in preterm infants. Pediatrics 1993; 91: 83–87.

    CAS  PubMed  Google Scholar 

  35. Sosenko IR, Rodriguez-Pierce M, Bancalari E . Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr 1993; 123: 975–982.

    Article  CAS  PubMed  Google Scholar 

  36. Lucas A . Early use of lipid infusions in very low birth weight infants.J Pediatr 1994; 125: 329–330.

    Article  CAS  PubMed  Google Scholar 

  37. Bloom BT, Mulligan J, Arnold C, Ellis S, Moffitt S, Rivera A et al. Improving growth of very low birth weight infants in the first 28 days. Pediatrics 2003; 112: 8–14.

    Article  PubMed  Google Scholar 

  38. Bhandari V, Bizzarro MJ, Shetty AH, Zhong XA, Page GP, Zhang H et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; in press.

Download references

Author information

Author notes

  1. M Akram Khan

    Present address: Division of Neonatolgy, University of South Dakota, Sioux Falls, SD, USA

  2. N L Brodsky

    Present address: Division of Neonatolgy, Children's Hospital of Philadelphia, Philadelphia, PA, USA

  3. M Akram Khan and B Kuzma-O'Reilly: These two authors contributed equally to this work.

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, Albert Einstein Medical Center, Philadelphia, PA, USA

    M Akram Khan, N L Brodsky & V Bhandari

  2. Mercy Children's Hospital, Toledo, OH, USA

    B Kuzma-O'Reilly

Authors
  1. M Akram Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Kuzma-O'Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N L Brodsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V Bhandari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Bhandari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akram Khan, M., Kuzma-O'Reilly, B., Brodsky, N. et al. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 26, 428–435 (2006). https://doi.org/10.1038/sj.jp.7211538

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211538

Keywords

This article is cited by

Search

Advanced search

Quick links